טוען...
Are the current recommendations for the use of aspirin in primary prevention of cardiovascular disease applicable in low-income countries?
Although evidence has accumulated that long-term aspirin therapy is beneficial in secondary prevention of cardiovascular disease (CVD), a lot of controversies persist regarding the benefit of aspirin use in primary prevention of CVD. In low-income countries (LIC) specifically, the decision to prescr...
שמור ב:
| הוצא לאור ב: | Vasc Health Risk Manag |
|---|---|
| Main Authors: | , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Dove Medical Press
2015
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4556041/ https://ncbi.nlm.nih.gov/pubmed/26345154 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/VHRM.S87398 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|